Examination of the phosphoenolpyruvate carboxykinase gene promoter in patients with noninsulin-dependent diabetes mellitus

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 2, 1996, Pages 503-506

  Ludwig, David S ^a,b   Vidal Puig, Antonio ^a   O'Brien, Richard M ^c   Printz, Richard L ^c   Granner, Daryl K ^c   Moller, David E ^a   Flier, Jeffrey S ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP);

ADULT; AGED; ARTICLE; CHROMOSOME 21; DNA SEQUENCE; FEMALE; GENE LOCATION; GENETIC VARIABILITY; GLUCONEOGENESIS; GLUCOSE METABOLISM; HUMAN; INSULIN RESISTANCE; INSULIN RESPONSE; INSULIN SYNTHESIS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROMOTER REGION;

ADOLESCENT; ADULT; BASE SEQUENCE; DIABETES MELLITUS, TYPE 2; GLUCONEOGENESIS; HUMANS; INSULIN; INSULIN RESISTANCE; LIVER; MOLECULAR SEQUENCE DATA; MUTATION; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); PROMOTER REGIONS (GENETICS);

EID: 0030041766     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.2.503     Document Type: Article

References (41)

1. DeFronzo RA, Bonadonna RC, Ferrannini E. 1992 Pathogenesis of NIDDM, a balanced overview. Diabetes Care. 15:318-368.
2. Firth R, Bell P, Rizza R. 1987 Insulin action in non-insulin-dependent diabetes mellitus: the relationship between hepatic and extrahepatic insulin resistance and obesity. Metabolism. 36:1091-1095.
3. Campbell PJ, Mandarino LJ, Gerich JE. 1988 Quantification of the relative impairment in actions of insulin on hepatic glucose production and peripheral glucose uptake in non-insulin-dependent diabetes mellitus. Metabolism. 37: 15-21.
4. Groop LC, Bonadonna RC, DelPrato S, et al. 1989 Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus: evidence for multiple sites of insulin resistance. J Clin Invest. 84:205-213.
5. Consoli A. 1992 Role of liver in pathophysiology of NIDDM. Diabetes Care. 15:430-441.
6. Consoli A, Nurjhan N, Capani F, Gerich J. 1989 Predominant role of gluconeogenesis in increased hepatic glucose production in NIDDM. Diabetes. 38:550-557.
7. Ballard FJ, Hanson RW. 1969 Purification of phosphoenolpyruvate carboxykinase from the cytosol fraction of rat liver and the immunochemical demonstration of differences between this enzyme and the mitochondrial phosphoenolpyruvate carboxykinase. J Biol Chem. 244:5625-5630.
8. Lamers VVH, Hanson RW, Meisner HM. 1982 cAMP stimulates transcription of the gene for cytosolic phosphoenolpyruvate carboxykinase in rat liver nuclei. Proc Natl Acad Sci USA. 79:5137-5141.
9. Sasaki K, Cripe TP, Koch SR, et al. 1984 Multihormonal regulation of phosphoenolpyruvate carboxykinase gene transcription: the dominant role of insulin. J Biol Chem. 259:15242-15251.
10. Granner D, Andreone T, Sasaki K, Beale E. 1983 Inhibition of transcription of phosphoenolpyruvate carboxykinase gene by insulin. Nature. 305:549-551.
11. Rosella G, Zajac JD, Kaczmarczyk SJ, Andrikopoulos S, Proietto J. 1993 Impaired suppression of gluconeogenesis by overexpression of a noninsulin- responsive phosphoenolpyruvate carboxykinase gene. Mol Endocrinol. 7:1456-1462.
12. Wynshaw-Boris A, Short JM, Loose DS, Hanson RW. 1986 Characterization of the phosphoenolpyruvate carboxykinase (GTP) promoter-regulatory region: multiple hormone regulatory elements and the effects of enhancers. J Biol Chem. 261:9714-9720.
13. Short JM, Wynshaw-Boris A, Short HP, Hanson RW. 1986 Characterization of the phosphoenolpyruvate carboxykinase (GTP) promoter-regulatory region: identification of cAMP and glucocorticoid regulatory domains. J Biol Chem. 261:9721-9726.
14. O'Brien RM, Lucas PC, Forest CD, Magnuson MA, Granner DK. 1990 Identification of a sequence in the PEPCK gene that mediates a negative effect of insulin on transcription. Science. 249:533-537.
15. O'Brien RM, Bonovich MT, Forest CD, Granner DK. 1991 Signal transduction convergence: phorbol esters and insulin inhibit phosphoenolpyruvate carboxykinase gene transcription through the same 10-base-pair sequence. Proc Natl Acad Sci USA. 88:6580-6584.
16. O'Brien RM, Granner DK. 1990 PEPCK gene as model of inhibitory effects of insulin on gene transcription. Diabetes Care. 13:327-329.
17. Granner D, O'Brien R, Imai E, et al. 1991 Complex hormone response unit regulating transcription of the phosphoenolpyruvate carboxykinase gene: from metabolic pathways to molecular biology. Recent Prog Horm Res. 47: 319-348.
18. Dammerman M, Sandkuijl LA, Halaas JL, Chung W, Breslow JL. 1993 An apolipoprotein CIII haplotype protective against hypertriglyceridemia is specified by promoter and 3′ untranslated region polymorphisms. Proc Natl Acad Sci USA. 90:4562-4566.
19. Bosch F, Pujol A, Pelegrin M, Ros CH, Valera A. 1944 Transgenic mice overexpressing p-enolpyruvate carboxykinase in the liver develop non-insulin-dependent diabetes mellitus [Abstract]. J Cell Biochem. 18A(Suppl):144.
20. 19a. Printz RL, Ardehali H, Koch S, Granner DK. 1995 Human hexokinase II mRNA and gene structure. Diabetes. 44:290-294.
21. Innis MA, Gelfand DH, Sninsky JJ, White TJ. 1990 PCR protocols: guide to methods and applications. San Diego: Academic Press.
22. Heukeshoven J, Dernick R. 1985 Simplified method for silver staining of proteins in polyacrylamide gels and mechanisms of silver staining. Electrophoresis. 6:103-112.
23. Orita M, Suzuki Y, Sekiya T, Hayashi K. 1989 Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics. 5:874-879.
24. Vidal-Puig A, Moller DE. 1994 Comparative sensitivity of alternative single strand conformation polymorphism (SSCP) methods. Biotechnology. 17:490-496.
25. Ausubel FM, Brent R, Kingston RE, et al. 1993 Current protocols in molecular biology, vol 1, unit 2. New York: Greene and Wiley.
26. Sanger F, Nicklen S, Coulson AR. 1977 DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA. 74:5463-5467.
27. Orita M, Iwahana H, Kanazawa H, Hayashi K, Sekiya T. 1989 Detection of polymorphisms of human DNA by gel electrophoresis as single-stand conformation polymorphism. Proc Natl Acad Sci USA. 86:2766-2770.
28. O'Rahilly S, Choi WH, Patel P, et al. 1991 Detection of mutations in insulin- receptor gene in NIDDM patients by analysis of single-stranded conformation polymorphisms. Diabetes. 40:777:782.
29. Olansky L, Janssen R, Welling C, Permutt A. 1992 Variability of the insulin gene in American Blacks with NIDDM: analysis by single-strand conformational polymorphisms. Diabetes. 41:742-749.
30. Bjørbæk C, Echwald SM, Hubricht P, et al. 1994 Genetic variants in promoters and coding regions of muscle glycogen synthase and the insulin-responsive GLUT 4 genes in NIDDM. Diabetes. 43:976-983.
31. Sheffield VC, Beck JS, Kwitek AE, Sandstrom DW, Stone EM. 1993 The sensitivity of single-strand conformation polymorphism analysis for the detection of single base substitutions. Genomics. 16:325-332.
32. Fan E, Levin DB, Glickman BW, Logan DM. 1993 Limitations in the use of SSCP analysis. Mutation Res. 288:85-92.
33. Hongyo T, Buzard GS, Calvert RJ, Weghorst M. 1993 'Cold SSCP:' a simple, rapid and non-radioactive method for optimized single-strand conformation polymorphism analyses. Nucleic Acids Res. 21:3637-3642.
34. Jennah M, Kessling A, Miller N, Humphries S. 1990 G to A substitution in the promoter region of the apolipoprotein AI gene is associated with elevated serum apolipoprotein AI and high density lipoprotein cholesterol concentrations. Mol Biol Med. 7:233-241.
35. Cooper D. 1992 Regulatory mutations and human genetic disease. Ann Med. 24:427-437.
36. Top B, Uitterlinden AG, van der Zee A, et al. 1992 Absence of mutations in the promoter region of the low density lipoprotein receptor gene in a large number of familial hypercholesterolaemia patients as revealed by denaturing gradient gel electrophoresis. Hum Genet. 89:561-565.
37. Tokuyama Y, Kanatsuka A, Suzuki Y, et al. 1994 Islet amyloid polypeptide gene: no evidence of abnormal promoter region in thirty-five type 2 diabetic patients. Diabetes Res Clin Pract. 22:99-105.
38. Shimokawa K, Sakura H, Otabe S, et al. 1994 Analysis of the glucokinase gene promoter in Japanese subjects with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab. 79:883-886.
39. Baibin M, Grubb A, Abrahamson M. 1992 Demonstration of sequence variations in the promoter region of the human cystatin C gene. Hoppe Seyler Z Biol Chem. 373:471-476.
40. Liu J, Hanson RW. 1991 Regulation of phosphoenolpyruvate carboxykinase (GTP) gene transcription. Mol Cell Biochem. 104:89-100.
41. O'Brien RM, Granner DK. 1991 Regulation of gene expression by insulin. Biochem J. 278:609-619.